Galecto Inc
NASDAQ:GLTO
Galecto Inc
Cash from Investing Activities
Galecto Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Galecto Inc
NASDAQ:GLTO
|
Cash from Investing Activities
$22.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Genmab A/S
CSE:GMAB
|
Cash from Investing Activities
-kr1.3B
|
CAGR 3-Years
18%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Cash from Investing Activities
-kr1.1B
|
CAGR 3-Years
-77%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Cash from Investing Activities
€286.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Cash from Investing Activities
-kr945.6m
|
CAGR 3-Years
21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-20%
|
Bioporto A/S
CSE:BIOPOR
|
Cash from Investing Activities
-kr277k
|
CAGR 3-Years
43%
|
CAGR 5-Years
29%
|
CAGR 10-Years
-25%
|
See Also
What is Galecto Inc's Cash from Investing Activities?
Cash from Investing Activities
22.3m
USD
Based on the financial report for Dec 31, 2023, Galecto Inc's Cash from Investing Activities amounts to 22.3m USD.
What is Galecto Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 1Y
80%
Over the last year, the Cash from Investing Activities growth was 80%.